Evidence map›Paper›PMID 28117423›Full record

ArticleScientific reports2017

Interstitial Inorganic Phosphate as a Tumor Microenvironment Marker for Tumor Progression.

Andrey A Bobko, Timothy D Eubank, Benoit Driesschaert, Ilirian Dhimitruka, Jason Evans, Rahman Mohammad, Elena E Tchekneva, Mikhail M Dikov, Valery V Khramtsov

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Andrey A BobkoIn Vivo Multifunctional Magnetic Resonance center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States.
Timothy D EubankIn Vivo Multifunctional Magnetic Resonance center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States.
Benoit DriesschaertIn Vivo Multifunctional Magnetic Resonance center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States.
Ilirian DhimitrukaDorothy M. Davis Heart &Lung Research Institute, and Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, United States.
Jason EvansDivision of Medical Oncology, Department of Internal Medicine, Ohio State University Medical Center, The James Comprehensive Cancer Center, Columbus, OH 43210, United States.
Rahman MohammadDivision of Medical Oncology, Department of Internal Medicine, Ohio State University Medical Center, The James Comprehensive Cancer Center, Columbus, OH 43210, United States.
Elena E TcheknevaDivision of Medical Oncology, Department of Internal Medicine, Ohio State University Medical Center, The James Comprehensive Cancer Center, Columbus, OH 43210, United States.
Mikhail M DikovDivision of Medical Oncology, Department of Internal Medicine, Ohio State University Medical Center, The James Comprehensive Cancer Center, Columbus, OH 43210, United States.
Valery V KhramtsovIn Vivo Multifunctional Magnetic Resonance center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States.
West Virginia University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USThe Ohio State University Wexner Medical Center · USThe Ohio State University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
In vivo monitoring of tumor microenvironment regulation for macrophagesR01CA194013 · NCI · WEST VIRGINIA UNIVERSITY · PI Timothy D Eubank, Valery V Khramtsov · 2015 to 2026
$3.5M
Profiling chemical tumor microenvironment: Application for diagnostics & therapyR01CA192064 · NCI · WEST VIRGINIA UNIVERSITY · PI EUBANK, TIMOTHY D, KHRAMTSOV, VALERY V · 2015 to 2024
$3.4M
Notch ligands in regulation of anti-cancer immunityR01CA175370 · NCI · OHIO STATE UNIVERSITY · PI CARBONE, DAVID P., DIKOV, MIKHAIL M · 2013 to 2017
$1.6M
Adenosine in Tumor-Host InteractionR01CA138923 · NCI · VANDERBILT UNIVERSITY · PI DIKOV, MIKHAIL M, FEOKTISTOV, IGOR · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA138923NCI NIH HHS R01 CA175370NCI NIH HHS R01 CA192064NCI NIH HHS R01 CA194013NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

Noninvasive in vivo assessment of chemical tumor microenvironment (TME) parameters such as oxygen (pO

Indexed as

Disease ProgressionTumor MicroenvironmentAcidosisAnimalsBiomarkers, TumorBreast NeoplasmsCell Line, TumorDisease Models, AnimalElectron Spin Resonance SpectroscopyFemaleHeterograftsHumansMammary Glands, AnimalMice, TransgenicOxygenPhosphatesBiomarkers, TumorOxygenPhosphates

Identifiers

PMID28117423
PMCPMC5259743
OpenAlexW2580162795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.